ACE2, COVID, COVID-19, Host Phosphoinositol-5 Kinase, Human, Human Neurons, PIK5K, Phosphoinositol, SARS, SARS-, SARS-CoV, SARS-CoV-2, TMPRSS2, anatomical abnormalities, angiotensin-converting enzyme 2, apilimod, astrocytes, brain cells, camostat, cathepsin L, cellular serine proteases, coronavirus disease, cytoplasm, double-stranded RNA, encephalopathy, endosomes, headache, human, human iPSC-derived neural cell model, human induced pluripotent stem cell (iPSC)-derived neurons, human neurons, impairment of memory, infected cells, nafamostat, neurological, neurological symptoms, neurons, patients, phosphatidyl-inositol, phosphatidyl-inositol 5 kinase, respiratory illness, seizures, serine, severe acute respiratory syndrome coronavirus, target cell, transmembrane serine protease 2, viral RNA, viral genome, viral late genes, viral surface spike protein